Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,045 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Phase I Combination Ixabepilone + Cisplatin

NCT00832117

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • The Cancer Institute Of New Jersey New Brunswick, New Jersey, United States
  • Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
  • Local Institution Lucca, Italy
View Trial Details
Completed

Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer

NCT00553254

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non Small Cell Lung, +8 more
Locations
  • Seoul National University Hospital, Department of Internal Medicine Seoul, South Korea
  • Severance Hospital, Yonsei University College of Medicine, Yonsei Cancer Center Seoul, South Korea
  • Samsung Medical Center, Department of Medicine Seoul, South Korea
View Trial Details
Completed

Single Arm on the Tolerability of Weekly Nab-paclitaxel

NCT01702844

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Rex Healthcare Raleigh, North Carolina, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients

NCT02879760

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Moncton Hospital Moncton, New Brunswick, Canada
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • Kingston General Hospital Kingston, Ontario, Canada
View Trial Details
Completed

A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC

NCT02451930

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Cancer Specialists St. Petersburg, Florida, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France
View all 16 locations
View Trial Details

Related conditions